hydroxyindoleacetic acid has been researched along with Anankastic Personality in 24 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA), the dopamine metabolite homovanillic acid, and the noradrenaline metabolite 4-hydroxy-3-methoxyphenyl glycol were measured in CSF before and after three weeks' treatment of severe obsessive-compulsive disorder with clomipramine hydrochloride." | 9.05 | Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects. ( Asberg, M; Bertilsson, L; Mellström, B; Sjöqvist, F; Thorén, P; Träskman, L, 1980) |
| "The CSF levels of corticotropin-releasing hormone, vasopressin, somatostatin, and oxytocin and of the monoamine metabolites 5-hydroxyindoleacetic acid, homovanillic acid, and 3-methoxy-4-hydroxyphenylglycol were measured in 17 children and adolescents with obsessive-compulsive disorder before and after long-term treatment with clomipramine." | 7.69 | Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine. ( Altemus, M; Leonard, HL; Potter, WZ; Rapoport, JL; Richter, D; Rubinow, DR; Swedo, SE, 1994) |
| "Limited neurobiological data have implicated central arginine vasopressin in the pathobiology of obsessive-compulsive disorder (OCD)." | 7.69 | Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls. ( Anderson, GM; Chappell, PB; Goodman, WK; Leckman, JF; McDougle, CJ; McSwiggan-Hardin, M; North, WG; Pauls, DL; Price, LH; Riddle, MA, 1994) |
| "Concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA), the dopamine metabolite homovanillic acid, and the noradrenaline metabolite 4-hydroxy-3-methoxyphenyl glycol were measured in CSF before and after three weeks' treatment of severe obsessive-compulsive disorder with clomipramine hydrochloride." | 5.05 | Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects. ( Asberg, M; Bertilsson, L; Mellström, B; Sjöqvist, F; Thorén, P; Träskman, L, 1980) |
| "The CSF levels of corticotropin-releasing hormone, vasopressin, somatostatin, and oxytocin and of the monoamine metabolites 5-hydroxyindoleacetic acid, homovanillic acid, and 3-methoxy-4-hydroxyphenylglycol were measured in 17 children and adolescents with obsessive-compulsive disorder before and after long-term treatment with clomipramine." | 3.69 | Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine. ( Altemus, M; Leonard, HL; Potter, WZ; Rapoport, JL; Richter, D; Rubinow, DR; Swedo, SE, 1994) |
| "Limited neurobiological data have implicated central arginine vasopressin in the pathobiology of obsessive-compulsive disorder (OCD)." | 3.69 | Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls. ( Anderson, GM; Chappell, PB; Goodman, WK; Leckman, JF; McDougle, CJ; McSwiggan-Hardin, M; North, WG; Pauls, DL; Price, LH; Riddle, MA, 1994) |
| "In light of prior data that the central administration of vasopressin in animals is associated with abnormal persistence of behaviors acquired under aversive conditioning, we studied the secretion of arginine vasopressin into the cerebrospinal fluid and plasma in patients with obsessive-compulsive disorder and controls." | 3.68 | Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder. ( Altemus, M; Demitrack, M; Dubbert, B; Gold, PW; Kalogeras, KT; Murphy, DL; Pigott, T, 1992) |
| "Tourette syndrome patients with high levels of obsessive-compulsive symptoms were compared with patients without these symptoms on urinary measures of serotonin and its major metabolite, 5-hydroxyindoleacetic acid (5HIAA)." | 3.68 | Urinary indoleamines in Tourette syndrome patients with obsessive-compulsive characteristics. ( Baker, GB; Bornstein, RA, 1992) |
| "Cerebrospinal fluid levels of 5-hydroxyindoleacetic acid, a metabolite of serotonin, were measured in relation to aggression, impulsivity, and social functioning in 29 children and adolescents with disruptive behavior disorders." | 3.68 | Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents. ( Brown, GL; Hamburger, S; Hibbs, E; Kruesi, MJ; Lenane, M; Potter, WZ; Rapoport, JL, 1990) |
| "Depression was by far the most important factor." | 1.26 | Cortisol in the CSF of depressed and suicidal patients. ( Asberg, M; Bertilsson, L; Lantto, O; Schalling, D; Träskman, L; Tybring, G, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (50.00) | 18.7374 |
| 1990's | 10 (41.67) | 18.2507 |
| 2000's | 2 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Markianos, M | 1 |
| Lafazanos, S | 1 |
| Koutsis, G | 1 |
| Sfagos, C | 1 |
| Seretis, A | 1 |
| Barbarich, N | 1 |
| Träskman, L | 2 |
| Tybring, G | 1 |
| Asberg, M | 2 |
| Bertilsson, L | 2 |
| Lantto, O | 1 |
| Schalling, D | 1 |
| Thorén, P | 1 |
| Mellström, B | 1 |
| Sjöqvist, F | 1 |
| Insel, TR | 2 |
| Murphy, DL | 4 |
| Lieberman, J | 1 |
| Altemus, M | 2 |
| Swedo, SE | 4 |
| Leonard, HL | 3 |
| Richter, D | 1 |
| Rubinow, DR | 2 |
| Potter, WZ | 5 |
| Rapoport, JL | 5 |
| Leckman, JF | 2 |
| Goodman, WK | 2 |
| North, WG | 1 |
| Chappell, PB | 1 |
| Price, LH | 1 |
| Pauls, DL | 1 |
| Anderson, GM | 2 |
| Riddle, MA | 2 |
| McSwiggan-Hardin, M | 1 |
| McDougle, CJ | 1 |
| de Groot, CM | 1 |
| Bornstein, RA | 2 |
| Baker, GB | 2 |
| Sasaki, K | 1 |
| Miyakawa, M | 1 |
| Sudo, T | 1 |
| Yoshizaki, F | 1 |
| Bridges, PK | 1 |
| Bartlett, JR | 1 |
| Sepping, P | 1 |
| Kantamaneni, BD | 1 |
| Curzon, G | 1 |
| Kruesi, MJ | 5 |
| Rettew, DC | 1 |
| Listwak, SJ | 1 |
| Berrettini, W | 1 |
| Stipetic, M | 2 |
| Hamburger, S | 2 |
| Gold, PW | 2 |
| Pigott, T | 1 |
| Kalogeras, KT | 1 |
| Demitrack, M | 1 |
| Dubbert, B | 1 |
| Hibbs, E | 1 |
| Lenane, M | 1 |
| Brown, GL | 1 |
| Hardin, MT | 1 |
| Swedo, S | 1 |
| Leonard, H | 1 |
| Mueller, EA | 1 |
| Alterman, I | 1 |
| Linnoila, M | 1 |
| Hamburger, SD | 2 |
| Cheslow, DL | 1 |
| Papeschi, R | 1 |
| Molina-Negro, P | 1 |
| Sourkes, TL | 1 |
| Erba, G | 1 |
| Baker, M | 1 |
| Goodwin, FK | 1 |
| Miller, H | 1 |
| Kotin, J | 1 |
| Bunney, WE | 1 |
| Coppen, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00004325] | 200 participants | Observational | 1988-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for hydroxyindoleacetic acid and Anankastic Personality
| Article | Year |
|---|---|
The psychopharmacological treatment of obsessive-compulsive disorder: a review.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Clinical Trials as Topic; Clomipramine; Double-Blind Meth | 1981 |
4 trials available for hydroxyindoleacetic acid and Anankastic Personality
| Article | Year |
|---|---|
Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects.
Topics: Adult; Clomipramine; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Met | 1980 |
The psychopharmacological treatment of obsessive-compulsive disorder: a review.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Clinical Trials as Topic; Clomipramine; Double-Blind Meth | 1981 |
Obsessive-compulsive disorder and serotonin: is there a connection?
Topics: Adult; Blood Platelets; Central Nervous System; Clinical Trials as Topic; Desipramine; Female; Human | 1985 |
L-tryptophan in affective disorders: indoleamine changes and differential clinical effects.
Topics: Affective Symptoms; Blood Platelets; Clinical Trials as Topic; Depression; Humans; Hydroxyindoleacet | 1974 |
20 other studies available for hydroxyindoleacetic acid and Anankastic Personality
| Article | Year |
|---|---|
CSF neurotransmitter metabolites and neuropsychiatric symptomatology in patients with normal pressure hydrocephalus.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Chromatography, High Pressure Liquid; Dopamine; Femal | 2009 |
Is there a common mechanism of serotonin dysregulation in anorexia nervosa and obsessive compulsive disorder?
Topics: Anorexia Nervosa; Comorbidity; Diagnosis, Differential; Family Health; Humans; Hydroxyindoleacetic A | 2002 |
Cortisol in the CSF of depressed and suicidal patients.
Topics: Adjustment Disorders; Clomipramine; Depression; Female; Homovanillic Acid; Humans; Hydrocortisone; H | 1980 |
Evidence for a biological hypothesis of obsessive-compulsive disorder.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Depressive Disorder; Dexamethasone; Diseases in Twins; | 1984 |
Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine.
Topics: Adolescent; Child; Clomipramine; Corticotropin-Releasing Hormone; Female; Homovanillic Acid; Humans; | 1994 |
Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls.
Topics: Adolescent; Adult; Age of Onset; Arginine Vasopressin; Biogenic Amines; Comorbidity; Dynorphins; Fam | 1994 |
Obsessive-compulsive symptom clusters and urinary amine correlates in Tourette syndrome.
Topics: Adolescent; Biogenic Amines; Child; Dopamine; Factor Analysis, Statistical; Female; Humans; Hydroxyi | 1995 |
[Evaluation of marble burying behavior: induced alteration of monoamine metabolism in mouse brain].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain; Disease Models, Animal; Dopamin | 1997 |
Precursors and metabolites of 5-hydroxytryptamine and dopamine in the ventricular cerebrospinal fluid of psychiatric patients.
Topics: Adult; Aged; Anxiety Disorders; Brain Diseases; Cerebral Ventricles; Depression; Female; Homovanilli | 1976 |
Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Arginine Vasopressin; Child; Clomipramine; Corticotr | 1992 |
Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Aged; Arginine Vasopressin; Corticotropin-Releasing Hormone; Female; Homovanillic | 1992 |
Urinary indoleamines in Tourette syndrome patients with obsessive-compulsive characteristics.
Topics: Adolescent; Child; Female; Humans; Hydroxyindoleacetic Acid; Indoleacetic Acids; Indoles; Male; Obse | 1992 |
Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents.
Topics: Adolescent; Age Factors; Aggression; Attention Deficit Disorder with Hyperactivity; Child; Child Beh | 1990 |
Low CSF 5HIAA and obsessions of violence: report of two cases.
Topics: Aggression; Female; Humans; Hydroxyindoleacetic Acid; Male; Obsessive-Compulsive Disorder; Thinking; | 1990 |
CSF somatostatin in childhood psychiatric disorders: a preliminary investigation.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorders; Depressi | 1990 |
Childhood obsessive compulsive disorder.
Topics: Adolescent; Anorexia Nervosa; Behavior Therapy; Child; Child, Preschool; Clomipramine; Epilepsy, Tem | 1986 |
Concentration gradient of CSF monoamine metabolites in children and adolescents.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorders; Child De | 1988 |
Lack of seasonal variation in pediatric lumbar cerebrospinal fluid neurotransmitter metabolite concentrations.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorders; Female; | 1989 |
The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Studies in patients with extrapyramidal disorders, epilepsy, and other diseases.
Topics: Adolescent; Adult; Basal Ganglia Diseases; Cerebral Palsy; Cerebral Ventricles; Diazepam; Dihydroxyp | 1972 |
Indoleamines and affective disorders.
Topics: Affective Symptoms; Brain Chemistry; Central Nervous System; Depression; Electroconvulsive Therapy; | 1972 |